# Johnson & Johnson Stock Surges Near 52-Week Highs After Impressive Q3 EarningsIn this episode, we analyze Johnson & Johnson's impressive market performance, with shares trading near $191 and approaching yearly highs. We break down J&J's better-than-expected Q3 results, including adjusted earnings of $2.80 per share (up 15% YoY) and quarterly revenue reaching nearly $24 billion. Discover why major institutional investors, who control over 70% of shares, continue increasing their positions and why analysts from Raymond James, Wells Fargo, and Citigroup have raised price targets to between $209-$215 per share. We also examine the strategic implications of J&J's planned Orthopedics business separation and what the upcoming $1.30 quarterly dividend (2.7% yield) means for income-focused investors. Learn why this healthcare giant continues to attract strong institutional support even as market conditions remain challenging.For more http://www.quietplease.aiStock up on these deals https://amzn.to/3QFpYIXThis content was created in partnership and with the help of Artificial Intelligence AI

Ver todos los episodios